Zacks Research Estimates Revvity’s Q2 Earnings (NYSE:RVTY)

Revvity Inc. (NYSE:RVTY) – Stock analysts at Zacks Research lifted their Q2 2026 earnings per share estimates for shares of Revvity in a research report issued on Thursday, June 25th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $1.22 for the quarter, up from their prior forecast of $1.21. The consensus estimate for Revvity’s current full-year earnings is $5.25 per share. Zacks Research also issued estimates for Revvity’s Q4 2026 earnings at $1.67 EPS, FY2026 earnings at $5.25 EPS, Q2 2027 earnings at $1.44 EPS, Q4 2027 earnings at $1.74 EPS, Q1 2028 earnings at $1.36 EPS and FY2028 earnings at $6.58 EPS.

Other analysts have also recently issued research reports about the stock. Barclays increased their price target on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. TD Cowen increased their price objective on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Wolfe Research started coverage on Revvity in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. JPMorgan Chase & Co. reduced their target price on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Finally, Stifel Nicolaus decreased their price target on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Four equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $108.33.

Revvity Price Performance

Shares of RVTY stock opened at $111.12 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The firm’s 50-day moving average is $97.89 and its two-hundred day moving average is $97.82. Revvity has a 12 month low of $81.22 and a 12 month high of $118.30. The company has a market capitalization of $12.40 billion, a PE ratio of 53.17, a price-to-earnings-growth ratio of 2.47 and a beta of 1.11.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm had revenue of $711.12 million for the quarter, compared to analysts’ expectations of $704.07 million. During the same quarter in the previous year, the company posted $1.01 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s dividend payout ratio (DPR) is 13.40%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in RVTY. Ascentis Independent Advisors acquired a new position in Revvity in the first quarter valued at $29,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Revvity during the second quarter worth about $32,000. Cromwell Holdings LLC boosted its stake in shares of Revvity by 141.4% during the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after buying an additional 198 shares during the period. MUFG Securities EMEA plc purchased a new position in shares of Revvity during the second quarter worth about $34,000. Finally, SJS Investment Consulting Inc. increased its position in Revvity by 5,210.0% in the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock valued at $47,000 after acquiring an additional 521 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.